Bio News
Researchers at the Gladstone Institutes and the University of California, San Francisco (UCSF), found that the COVID-19 viral protein ORF8 hijacks macrophages and worsens lung inflammation.
Macrophages exposed to ORF8 produced more ACE2, the entry pathway used by the virus, making them more susceptible to infection.
The researchers reported that an antibody blocking IL-17RA reduced inflammation and lung damage in a mouse model.
Biobook Team
biobookmedia@biobook.co.krIonkura Reports 20.8-Month Median Survival in Phase 1 Trial for Metastatic Eye Cancer
Verastem’s VS-7375 Shows Response Rates of Up to 50% in Pancreatic Cancer; Phase 3 Trial to Begin This Year
Pfizer to Co-Develop Sec61 Inhibitors With Enodia in Deal Worth Up to $500 Million
Galderma to Acquire ZO Skin Health for $1.5 Billion, Expanding Dermatology Portfolio
Verdiva halts GLP-1 transition trial, citing ‘market changes’
Stryker to Invest $400 Million in CMR Surgical, Expand Robotic Surgery
